கத்தோலிக் பல்கலைக்கழகம் ஆஃப் கொரியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கத்தோலிக் பல்கலைக்கழகம் ஆஃப் கொரியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கத்தோலிக் பல்கலைக்கழகம் ஆஃப் கொரியா Today - Breaking & Trending Today

Pandemic surges in South Korea as government pushes to end social distancing


Pandemic surges in South Korea as government pushes to end social distancing
The number of daily new COVID-19 cases is rising again in South Korea, reaching their highest levels in months, including 1,275 infections on July 7. The number of new cases in Seoul the previous day reached 583, the most in the city since the pandemic began. The numbers continue to climb as the more dangerous and contagious delta variant begins to take hold.
However, central and local governments are pushing to remove even the limited measures in place to control the virus. Since the end of January, new cases of COVID-19 in South Korea have ranged between 300 and 700 per day, but plans remain to relax social distancing measures. On June 24, when the government announced it would proceed, despite an uptick in cases, the seven-day national average for new infections stood at 489. As of July 6, the number had shot up to 768. In total, more than 2,000 people have died from the virus. ....

Soult Ukpyolsi , South Korea , Inch On Gwangyoksi , Kyonggi Do , Korean Confederation Of Trade Unions , College Of Medicine , Catholic University Of Korea , Gyeonggi Province , Moon Jae In , Korea Times , Korean Confederation , Trade Unions , Korea Herald , Paik Soon Young , Catholic University , தெற்கு கொரியா , கொரியன் கூட்டமைப்பு ஆஃப் வர்த்தகம் தொழிற்சங்கங்கள் , கல்லூரி ஆஃப் மருந்து , கத்தோலிக் பல்கலைக்கழகம் ஆஃப் கொரியா , க்யேஓங்க்கி மாகாணம் , நிலா ஜே இல் , கொரியா முறை , கொரியன் கூட்டமைப்பு , வர்த்தகம் தொழிற்சங்கங்கள் , கொரியா ஹெரால்ட் , பைக் விரைவில் இளம் ,

TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI


May 17, 2021
A de-escalation antiplatelet strategy of switching from the more-potent ticagrelor (Brilinta; AstraZeneca) to clopidogrel at 1 month after PCI for acute MI is superior to continuing on ticagrelor and aspirin in terms of net clinical benefit, according to the TALOS-AMI trial.
“This study was conducted only in South Korea. However, although the prevalence of the CYP2C19 loss-of-function allele is significantly higher in Koreans than in other ethnic groups, this study showed the clinical safety of switching in this population, suggesting the potential of applying this de-escalation strategy to other ethnic groups,” said Kiyuk Chang, MD, PhD (The Catholic University of Korea, Seoul, Republic of Korea), who presented the findings in a late-breaking clinical trial session yesterday at the American College of Cardiology 2021 Scientific Session. ....

New York , United States , Soult Ukpyolsi , South Korea , Ann Arbor , Republic Of Korea , Claire Duvernoy , Roxana Mehran , Kiyuk Chang , Md University Of Michigan Health System , American College Of Cardiology , Catholic University Of Korea , Catholic University , American College , Michigan Health System , Icahn School , Mount Sinai , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , ஆண்டு ஆர்பர் , குடியரசு ஆஃப் கொரியா , ரோக்ஷணா மெஹ்ரான் , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் , கத்தோலிக் பல்கலைக்கழகம் ஆஃப் கொரியா , கத்தோலிக் பல்கலைக்கழகம் ,